Poly(amino acid) nanoformulation of cyclin-dependent kinase 4 and 6 inhibitor for molecularly targeted immunotherapy in triple-negative breast cancer
Xue Wei, Ming Yang, Haoyang Zou, Songjie Shen, Yuechong Li, Li Chen, Yahui Liu, Di Li, Jianxun Ding
Topics & Concepts
Triple-negative breast cancerCancer researchTargeted therapyImmunotherapyChemistryCyclin-dependent kinase 4Breast cancerCancerPharmacologyCell cycleMedicineApoptosisBiochemistryCyclin-dependent kinase 2Internal medicineAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysChronic Lymphocytic Leukemia Research